Funding to the Investigational Medicine Units (IMU) is provided to support infrastructure for clinician-investigators, such as dedicated space and beds for in-patient and outpatient research, computer hardware and software systems for data management and analysis, as well as manpower “infrastructure” such as clinical pharmacologists, specialised research nurses and biostatisticians. The IMUs focus on early phase trials (Phase 1 and 2a), preferably first-in-man type; and encourages collaborative efforts across different trial units, institutions, across clusters and outside Singapore to develop innovative though leadership and global competitiveness.   

For information on NUHS IMU, click here.
For information on SingHealth IMU, click here.
For more information on NHG IMU, click here.